Showing results (91-100 of 3,654) with videos related to

Sort By:
Pageof 366
Breast Cancer Research : BCR|July 26, 2019
Glucocorticoid receptor modulation decreases ER-positive breast cancer cell proliferation and suppresses wild-type and mutant ER chromatin associationEva Tonsing-Carter, Kyle M Hernandez, Caroline R Kim, et al.
Breast Cancer Research : BCR|March 15, 2019
Parity, breastfeeding, and breast cancer risk by hormone receptor status and molecular phenotype: results from the Nurses' Health StudiesRenée T Fortner, Julia Sisti, Boyang Chai, et al.
Breast Cancer Research : BCR|March 15, 2019
Impact of obesity on breast cancer recurrence and minimal residual diseaseBrett L Ecker, Jun Y Lee, Christopher J Sterner, et al.
Breast Cancer Research : BCR|September 20, 2019
Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesisFelipe Batalini, Ellie G Peacock, Lindsey Stobie, et al.
Breast Cancer Research : BCR|September 20, 2019
Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progressionJiang Ren, Marcel Smid, Josephine Iaria, et al.
Breast Cancer Research : BCR|August 18, 2019
Disease trajectories and mortality among women diagnosed with breast cancerHaomin Yang, Yudi Pawitan, Wei He, et al.
Breast Cancer Research : BCR|February 20, 2019
MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancerYoshimi Endo Greer, Samuel F Gilbert, Brunilde Gril, et al.
Breast Cancer Research : BCR|February 24, 2019
Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98Kevin H Kensler, Meredith M Regan, Yujing J Heng, et al.
Breast Cancer Research : BCR|March 10, 2019
Impact of short-term low-dose tamoxifen on molecular breast imaging background parenchymal uptake: a pilot studyCarrie B Hruska, Katie N Hunt, Amy Lynn Conners, et al.
Breast Cancer Research : BCR|January 24, 2021
Leronlimab, a humanized monoclonal antibody to CCR5, blocks breast cancer cellular metastasis and enhances cell death induced by DNA damaging chemotherapyXuanmao Jiao, Min Wang, Zhao Zhang, et al.
Pageof 366